stockrowPerspective Therapeutics, Inc. (CATX) vs Sera Prognostics, Inc. (SERA)
- Perspective Therapeutics, Inc. CATX 0.86 +8.86%
- Sera Prognostics, Inc. SERA 2.09 +0.48%
Perspective Therapeutics, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. and Sera Prognostics, Inc. are of similar size ($90.0M and $82.1M). Sera Prognostics, Inc. grew revenue faster over the last twelve months: 1.05% against −66.9%. Perspective Therapeutics, Inc. has the higher net margin (−28,468.0% vs −34,866.7%) and the higher return on invested capital (−88.4% vs −278.6%). Across the 18 metrics below, Perspective Therapeutics, Inc. leads on 11 and Sera Prognostics, Inc. on 7.
Valuation
Profitability
| Metric | CATX | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 57.76% |
| Operating margin | (30,619.07%) | (38,755.21%) | (15.07%) |
| Net margin | (28,467.97%) | (34,866.67%) | (14.45%) |
| Free cash flow margin | (29,630.07%) | (30,198.96%) | (3.88%) |
| Return on equity | (39.50%) | (49.73%) | (10.35%) |
| Return on assets | (33.14%) | (35.59%) | (17.26%) |
| Return on invested capital | (88.41%) | (278.58%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack